SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 05/07/2019
Entire Document
 

 

In re: Pernix Sleep, Inc. et al. Case No. 19-10323 (CSS)
Debtors Reporting Period: February 18, 2019 - March 31, 2019

 

MOR – la
Schedule of Disbursements by Debtor Entity(1)
For the Period: February 18, 2019 - March 31, 2019
(Unaudited)

 

$ USD '000s
Debtors
  Case Number  February 18, 2019 - March 31, 2019  Cumulative
Since Filing
Pernix Therapeutics, LLC  19-10329  $(15,624)  $(15,624)
Cypress Pharmaceuticals, Inc.  19-10330   (959)   (959)
Pernix Ireland Limited  19-10325   (1)   (1)
Pernix Ireland Pain Designated Activity Company  19-10327   (153)   (153)
Pernix Therapeutics Holdings, Inc.(2)  19-10324   (14,529)   (14,529)
Gaine, Inc.  19-10335   -      -   
Hawthorn Pharmaceuticals, Inc.  19-10336   -      -   
Macoven Pharmaceuticals, L.L.C.  19-10334   -      -   
Pernix Holdco 1, LLC  19-10331   -      -   
Pernix Holdco 2, LLC  19-10332   -      -   
Pernix Holdco 3, LLC  19-10326   -      -   
Pernix Manufacturing, LLC  19-10328   -      -   
Pernix Sleep, Inc.  19-10323   -      -   
Respicopea, Inc.  19-10333   -      -   
Total     $(31,265)  $(31,265)

 

Notes:

(1) The Schedule of Disbursements is presented on a book basis. The five entities included on the schedule represent all disbursements of the Debtors. The other remaining nine Debtor entities do not make disbursements.

(2) Pernix Therapeutics Holdings, Inc. disbursements includes the payoff of the pre-petition ABL and interest totaling $14,528,717.

 

5